Paradigm Therapeutics Incorporated Company Profile

07:43 EST 23rd November 2017 | BioPortfolio

Paradigm Therapeutics is an emerging drug discovery company focussed on the pharmaceutical exploitation of the human genome.

The race to define biological function of the thousands of uncharacterised human proteins is the new hallmark of modern drug discovery: Unlocking the physiology of novel proteins is a vital prerequisite to rational drug development on truly novel targets and the basis by on which a strong intellectual property (IP) can be developed. Paradigm Therapeutics has established a powerful genetics based biological platform that is already delivering function and IP on the most novel of human proteins and is now ideally positioned to start development of novel drugs to its targets.


Physiological Laboratories
United Kingdom


Phone: 01223 333 841
Fax: 01223 333 841

News Articles [609 Associated News Articles listed on BioPortfolio]

Paradigm Diagnostics Announces Major Price Reduction in Flagship Paradigm Cancer Diagnostic (PCDx)

  Life Sciences Jobs   ...

BCBS of Mich. to cover Paradigm Spine's interlaminar stabilization device

Paradigm Spine obtained a positive coverage policy decision from Blue Cross Blue Shield of Michigan for its coflex Interlamin -More- 

Paradigm Outcomes Acquires Surgical Management Solution ForeSight Medical

Paradigm Outcomes, a provider of medical management services for catastrophically injured workers, has acquired ForeSight Medical, a comprehensive suite of surgical management solutions in the workers...

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

A new paradigm for treating transcription factor-driven cancers

In the current issue of Proceedings of the National Academy of Sciences, researchers from Nationwide Children's Hospital describe a new paradigm for treating transcription factor-driven cancers. The s...

Prediction of antibiotic resistance: time for a new preclinical paradigm?

Risk assessment for the development of antibiotic resistance against a new drug candidate is of paramount importance in preclinical development. In this Opinion article, Sommer et al. propose a new pr...

Technology should be used to boost empathy-based medicine

Existing digital technologies must be exploited to enable a paradigm shift in current healthcare delivery which focuses on tests, treatments and targets rather than the therapeutic benefits of empathy...

Genmedica: Alec Mian. Treating OSIF in type 2 diabetes, representing a major paradigm shift for this disease

In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Alec Mian, CEO at Genmedica Therapeutics about their novel approach to loo...

PubMed Articles [645 Associated PubMed Articles listed on BioPortfolio]

A New Paradigm. "Learn - Learn More"; Dose-Exposure-Response at the Centre of Drug Development and Regulatory Approval.

Are Nurse Leaders Prepared to Lead Across the Continuum of Care in the New Paradigm?

The movement toward linking reimbursement with outcomes necessitates providing care across a continuum of settings, leading to the need for a new healthcare paradigm. Issues related to shifting to thi...

Spelling with a Small Mobile Brain-Computer Interface in a Moving Wheelchair.

Research into Brain-Computer Interfaces (BCIs), which spell words using brain signals, has revealed that a desktop version of such a speller, the edges paradigm, offers several advantages: This edges ...

A New Preclinical Paradigm for Testing Anti-Aging Therapeutics.

Testing drugs for anti-aging effects has historically been conducted in mouse life-span studies, but are costly and time consuming, and more importantly, difficult to recapitulate in humans. In additi...

The body composition profile is associated with response to anti-TNF therapy in Crohn's disease and may offer an alternative dosing paradigm.

Anti-tumour necrosis factor (TNF)s form a major part of therapy in Crohn's disease and have a primary nonresponse rate of 10%-30% and a secondary loss of response rate of 5% per year. Myopenia is prev...

Clinical Trials [309 Associated Clinical Trials listed on BioPortfolio]

Feasibility Study of Effective Methods for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness

Feasibility study to compare the effectiveness of the Paradigm Sensor Augmented System versus subjects continuing to administer insulin in multiple dose injections. Evaluate the educationa...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes

The purpose of this study is to determine whether Type 1 Diabetic subjects using the Paradigm 722 System, which is a glucose sensor-augmented insulin pump, can improve glycemic control whe...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy

Patients with refractory epilepsy who are candidates for a treatment with vagus nerve stimulation will be prospectively randomized into 3 arms with different vagus nerve stimulation paradi...

Companies [1266 Associated Companies listed on BioPortfolio]

Paradigm Therapeutics Incorporated

Paradigm Therapeutics is an emerging drug discovery company focussed on the pharmaceutical exploitation of the human genome. The race to define biological function of the thousands of uncharacterised ...

The Paradigm Award Committee

The Paradigm Award was created to honor hospitals that have gone above and beyond in their efforts to foster efficient labor practices without resorting to workforce reductions or dramatic top-down ma...

Paradigm Medical Industries

Founded in 1996, Paradigm Medical Industries, Inc. develops, manufactures, and markets diagnostic and surgical equipment for the ophthalmic market. The company specialized in powerful, easy-to-use, v...

Nimbus Therapeutics, LLC

Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pi...

Advance Paradigm Incorporated

Advance Paradigm is a leading independent provider of health benefit management services, providing pharmacy benefit management, disease management and clinical research programs. Advance Paradigm's m...

More Information about "Paradigm Therapeutics Incorporated" on BioPortfolio

We have published hundreds of Paradigm Therapeutics Incorporated news stories on BioPortfolio along with dozens of Paradigm Therapeutics Incorporated Clinical Trials and PubMed Articles about Paradigm Therapeutics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Paradigm Therapeutics Incorporated Companies in our database. You can also find out about relevant Paradigm Therapeutics Incorporated Drugs and Medications on this site too.

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Corporate Database Quicklinks

Searches Linking to this Company Record